Skip to main content
. Author manuscript; available in PMC: 2012 Mar 23.
Published in final edited form as: J Urol. 2009 Dec 16;183(2):622–628. doi: 10.1016/j.juro.2009.09.083

Table 2.

Association of anatomic characteristics with weight categories in the SISTEr and TOMUS Trials

Variable SISTER Trial TOMUS Trial
Normal Overweight Obese Normal Overweight Obese
Resting angle 1 8.8(15.0) 14.9(15.6) 19.0(19.5)*** 6.7(13.0) 5.5(11.7) 11.8(13.5)***
Strain angle1 59.2(18.8) 60.0(17.8) 60.8(18.4) 46.9(20.2) 44.7(21.5) 46.5(20.5)
Delta1 50.5(18.0) 45.1(17.6) 41.7(18.1)*** 40.3(18.7) 39.2(20.5) 34.7(17.9)**
POP-Q [N(%)] 2
   Stages 0–I 33 (23%) 54 (25%) 74 (26%) 64 (47%) 82 (43%) 120 (46%)
   Stage II 85 (60%) 119 (55%) 180 (62%) 60 (44%) 93 (48%) 124 (47%)
   Stage III 24 (17%) 45 (21%) 36 (12%) 13 (9%) 17 (9%) 18 (7%)
Point Ba1 −0.4(2.1) −0.4(2.0) −0.8(1.6)* −1.2(1.5) −1.2(1.8) −1.4 (1.3)
Point Bp1 −1.7(1.8) −1.6(1.7) −1.7(1.4) −1.9(1.3) −1.8(1.8) −2.0 (1.1)
Point Gh1 3.5(1.0) 3.5(1.3) 3.7(1.2) 3.3(1.0) 3.4(1.0) 3.6(1.1)*
Brink score 1 9.1(2.0) 8.9(2.2) 8.9(2.0) 8.9(1.8) 8.7(2.1) 8.7 (2.0)

Mean and SD were presented except POP-Q;

1

Equality of means tested by ANOVA

2

Equality of frequencies tested by Chi-square

*

0.01≤P< 0.05

**

0.001≤ P <0.01

***

P<0.001